Healthcare & Pharmaceuticals
🟢 SERP-Grounded (Light Telemetry)
Charles River Laboratories
Programmatic AI Search & Model Visibility Audit
Share of Model (SOM)The percentage of time frontier AI models (ChatGPT, Claude, Gemini) recommend this brand for high-intent category queries.
45.0%
+7.0% 30-Day MomentumThe rolling 30-day change in algorithmic Share of Model. Positive momentum indicates increasing AI mindshare.
🧠 Neural Valency:DominantThe contextual sentiment of the AI's recommendation. 'Dominant' implies strong conviction, while 'Vulnerable' implies the model heavily conditions its recommendation.
Algorithmic Threat Detection
Primary Competitor Threat
Labcorp Drug Dev
Competitor Displacement Rate
18.0%
Competitors are displacing Charles River Laboratories in 18.0% of high-intent buyer queries.The frequency at which AI models actively suggest a competitor as a superior alternative to this brand.
Algorithmic Rationale: Labcorp Drug Development offers integrated solutions for preclinical and clinical research, often outperforming Charles River for end-to-end service queries.
Missing AI Citations:High-authority domains (e.g., Reddit, G2) that models cite to justify recommending competitors, where this brand currently lacks presence.
[labcorp.com][iqvia.com]⚠️ Identified Vulnerability:Integrated Services
Primary Threat Identified:Labcorp Drug Dev
Target Persona:Biotech Startups seeking CRO services
🚨 Threat Velocity:6/10An algorithmic urgency score (1-10) indicating how rapidly competitors are capturing this brand's historical AI search share.
Unlock Full Threat Report (30 Free Credits)